The Drug Topics BPA Statement
Ajovy Demonstrates Safety, Efficacy in Pediatric Migraineurs
The calcitonin gene-related peptide monoclonal antibody significantly reduced the number of monthly migraine days.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Evaluating Pediatric Migraine Options Uncovers Challenges
No medications were associated with improved quality of life or reduced headache duration.
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Tirzepatide Bests Semaglutide in Relative, Average Weight Loss in Obesity, Overweight
The drugs were compared over a 72-week study period.
OTC Supplement Use Common For Symptom Management in Rheumatic Diseases
Pain, fatigue, and sleep disturbances are common symptoms with rheumatic diseases.